Tarzena Capsules 0.25mg, from Pfizer, contains Talazoparib (YJ code: 4291081M2029, standard: 0.25mg 1 capsule). As a poly ADP-ribose polymerase (PARP) inhibitor, it is used for advanced breast cancer with germline BRCA mutations and homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer, by inhibiting PARP1/2 and leading to DNA damage accumulation in cancer cells.
Tarzena Capsules 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
